Pyxis Oncology in the NEWS

Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

On March 18, 2025, Pyxis Oncology (PYXS) - a clinical-stage firm developing next-generation therapeutics for difficult-to-treat cancers, reported financial results for the year and quarter ending December 31, 2024, and provided a business update.
From Pyxis Oncology

Lara . . .